Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors

被引：460

作者：

Liao, Jeffrey Jie-Lou

机构：

[1] TransTech Pharma, High Point, NC 27265 USA

[2] Duke Univ, Dept Chem, Durham, NC 27708 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 03期

关键词：

GROWTH-FACTOR RECEPTOR; CYCLIN-DEPENDENT KINASE; STRUCTURE-GUIDED DESIGN; ABL TYROSINE KINASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ANTITUMOR-ACTIVITY; DRUG DISCOVERY; AURORA KINASE; MAP KINASE;

D O I：

10.1021/jm0608107

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：409 / 424

页数：16

共 133 条

[1]

Abrams TJ, 2003, MOL CANCER THER, V2, P1011

[2] Kinase inhibition with BAY 43-9006 n renal cell carcinoma [J].

Ahmad, T ;

Eisen, T .

CLINICAL CANCER RESEARCH, 2004, 10 (18) :6388S-6392S

[3] Computational methods to predict binding free energy in ligand-receptor complexes [J].

Ajay ;

Murcko, MA .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (26) :4953-4967

[4]

[Anonymous], [No title captured], Patent No. 9935146

[5] Halogen bonds in biological molecules [J].

Auffinger, P ;

Hays, FA ;

Westhof, E ;

Ho, PS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) :16789-16794

[6] The specificities of protein kinase inhibitors: an update [J].

Bain, J ;

McLauchlan, H ;

Elliott, M ;

Cohen, P .

BIOCHEMICAL JOURNAL, 2003, 371 :199-204

[7] Studies leading to the identification of ZD1839 (Iressa™):: An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer [J].

Barker, AJ ;

Gibson, KH ;

Grundy, W ;

Godfrey, AA ;

Barlow, JJ ;

Healy, MP ;

Woodburn, JR ;

Ashton, SE ;

Curry, BJ ;

Scarlett, L ;

Henthorn, L ;

Richards, L .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) :1911-1914

[8] The Akt/PKB family of protein kinases: A review of small molecule inhibitors and progress towards target validation [J].

Barnett, SF ;

Bilodeau, MT ;

Lindsley, CW .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) :109-125

[9] The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2 [J].

Battistutta, R ;

Sarno, S ;

De Moliner, E ;

Papinutto, E ;

Zanotti, G ;

Pinna, LA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29618-29622

[10] Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole [J].

Battistutta, R ;

Mazzorana, M ;

Sarno, S ;

Kazimierczuk, Z ;

Zanotti, G ;

Pinna, LA .

CHEMISTRY & BIOLOGY, 2005, 12 (11) :1211-1219

← 1 2 3 4 5 6 7 8 9 10 →